Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Feb 21;282(6264):595–598. doi: 10.1136/bmj.282.6264.595

Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease.

A Dal Canton, D Russo, R Gallo, G Conte, V E Andreucci
PMCID: PMC1504392  PMID: 6781585

Abstract

Muzolimine was administered by mouth to 24 patients with creatinine clearances ranging from 4 to 28 ml/min to treat oedema or hypertension, or both. In four of these 24 patients muzolimine was given after intravenous high-dose frusemide had been unsuccessful. Muzolimine significantly increased urine volume and excretions of sodium, chloride, and potassium ions. Its diuretic efficacy was further shown by a mean reduction in body-weight of 8% and by the disappearance of oedema in all affected patients, even those refractory to intravenous frusemide. No rebound phenomenon was observed after the drug was stopped. Mean blood pressure was reduced in all hypertensive patients. Blood pressure was restored to normal in five out of seven patients treated with muzolimine alone and 10 out of 11 in whom muzolimine had been added to previously unsatisfactory antihypertensive treatment. Muzolimine was well tolerated by all patients. Muzolimine appears to be the diuretic of choice when treating patients with advanced renal disease.

Full text

PDF
595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison M. E., Kennedy A. C. Diuretics in chronic renal disease: a study of high dosage frusemide. Clin Sci. 1971 Sep;41(3):171–187. doi: 10.1042/cs0410171. [DOI] [PubMed] [Google Scholar]
  2. MAHER J. F., SCHREINER G. E. STUDIES ON ETHACRYNIC ACID IN PATIENTS WITH REFRACTORY EDEMA. Ann Intern Med. 1965 Jan;62:15–29. doi: 10.7326/0003-4819-62-1-15. [DOI] [PubMed] [Google Scholar]
  3. Meng K. Zum renalen Wirkungsmechanismus der Diuretika. Dtsch Med Wochenschr. 1970 Oct 9;95(41):2089–2094. doi: 10.1055/s-0028-1108786. [DOI] [PubMed] [Google Scholar]
  4. Mussche M., Lameire N. The mechanism of action of Bay g 2821: a new diuretic. Curr Med Res Opin. 1977;4(7):462–468. doi: 10.1185/03007997709109334. [DOI] [PubMed] [Google Scholar]
  5. Yeh B. P., Tomko D. J., Stacy W. K., Bear E. S., Haden H. T., Falls W. F., Jr Factors influencing sodium and water excretion in uremic man. Kidney Int. 1975 Feb;7(2):103–110. doi: 10.1038/ki.1975.15. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES